1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Anti-Viral Therapies Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Anti-Viral Therapies Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Anti-Viral Therapies Market Regional Analysis
6.2 Europe Anti-Viral Therapies Market Revenue 2017-2027 (US$ Million)
6.3 Europe Anti-Viral Therapies Market Forecast Analysis
7. Europe Anti-Viral Therapies Market Analysis – by Type
7.1 Generic Drugs
- 7.1.1 Overview
- 7.1.2 Generic Drugs: Europe Anti-Viral Therapies Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Branded Drugs
- 7.2.1 Overview
- 7.2.2 Branded Drugs: Europe Anti-Viral Therapies Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. Europe Anti-Viral Therapies Market Analysis – by Mechanism of Action
8.1 Nucleotide Polymerase Inhibitors
- 8.1.1 Overview
- 8.1.2 Nucleotide Polymerase Inhibitors: Europe Anti-Viral Therapies Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Reverse Transcriptase Inhibitors
- 8.2.1 Overview
- 8.2.2 Reverse Transcriptase Inhibitors: Europe Anti-Viral Therapies Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Protease Inhibitors
- 8.3.1 Overview
- 8.3.2 Protease Inhibitors: Europe Anti-Viral Therapies Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. Europe Anti-Viral Therapies Market Analysis – by Application
9.1 HIV
- 9.1.1 Overview
- 9.1.2 HIV: Europe Anti-Viral Therapies Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.2 Hepatitis
- 9.2.1 Overview
- 9.2.2 Hepatitis: Europe Anti-Viral Therapies Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.3 Virus Influenza
- 9.3.1 Overview
- 9.3.2 Virus Influenza: Europe Anti-Viral Therapies Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.4 Herpes
- 9.4.1 Overview
- 9.4.2 Herpes: Europe Anti-Viral Therapies Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.5 Other Applications
- 9.5.1 Overview
- 9.5.2 Other Applications: Europe Anti-Viral Therapies Market – Revenue and Forecast, 2017-2027 (US$ Million)
10. Europe Anti-Viral Therapies Market – Europe Analysis
10.1 Overview
10.2 Europe
- 10.2.1 Europe Anti-Viral Therapies Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 10.2.1.1 Europe Anti-Viral Therapies Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 UK:
Europe Anti-Viral Therapies Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.1.1 UK: Europe Anti-Viral Therapies Market Breakdown, by Type
- 10.2.1.1.2 UK: Europe Anti-Viral Therapies Market Breakdown, by Mechanism of Action
- 10.2.1.1.3 UK: Europe Anti-Viral Therapies Market Breakdown, by Application
- 10.2.1.2 Germany:
Europe Anti-Viral Therapies Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.2.1 Germany: Europe Anti-Viral Therapies Market Breakdown, by Type
- 10.2.1.2.2 Germany: Europe Anti-Viral Therapies Market Breakdown, by Mechanism of Action
- 10.2.1.2.3 Germany: Europe Anti-Viral Therapies Market Breakdown, by Application
- 10.2.1.3 France:
Europe Anti-Viral Therapies Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.3.1 France: Europe Anti-Viral Therapies Market Breakdown, by Type
- 10.2.1.3.2 France: Europe Anti-Viral Therapies Market Breakdown, by Mechanism of Action
- 10.2.1.3.3 France: Europe Anti-Viral Therapies Market Breakdown, by Application
- 10.2.1.4 Russia:
Europe Anti-Viral Therapies Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.4.1 Russia: Europe Anti-Viral Therapies Market Breakdown, by Type
- 10.2.1.4.2 Russia: Europe Anti-Viral Therapies Market Breakdown, by Mechanism of Action
- 10.2.1.4.3 Russia: Europe Anti-Viral Therapies Market Breakdown, by Application
- 10.2.1.5 Italy:
Europe Anti-Viral Therapies Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.5.1 Italy: Europe Anti-Viral Therapies Market Breakdown, by Type
- 10.2.1.5.2 Italy: Europe Anti-Viral Therapies Market Breakdown, by Mechanism of Action
- 10.2.1.5.3 Italy: Europe Anti-Viral Therapies Market Breakdown, by Application
- 10.2.1.6 Rest of Europe:
Europe Anti-Viral Therapies Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.6.1 Rest of Europe: Europe Anti-Viral Therapies Market Breakdown, by Type
- 10.2.1.6.2 Rest of Europe: Europe Anti-Viral Therapies Market Breakdown, by Mechanism of Action
- 10.2.1.6.3 Rest of Europe: Europe Anti-Viral Therapies Market Breakdown, by Application
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 AbbVie Inc.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 GlaxoSmithKline plc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 AstraZeneca
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 F. HOFFMANN-LA ROCHE LTD
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Johnson and Johnson Services, Inc.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Get Free Sample For Europe Anti-Viral Therapies Market
